1 Cancer Council Queensland, Brisbane 4006, Australia ; 2 School of Mathematical Sciences, Queensland University of Technology, Brisbane 4000, Australia ; 3 Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia ; 4 Griffith Health Institute, Griffith University, Gold Coast 4222, Australia ; 5 School of Public Health and Social Work, Queensland University of Technology, Brisbane 4000, Australia.
Cancer Biol Med. 2014 Jun;11(2):101-15. doi: 10.7497/j.issn.2095-3941.2014.02.005.
To provide an overview of the incidence and mortality of female breast cancer for countries in the Asia-Pacific region.
Statistical information about breast cancer was obtained from publicly available cancer registry and mortality databases (such as GLOBOCAN), and supplemented with data requested from individual cancer registries. Rates were directly age-standardised to the Segi World Standard population and trends were analysed using joinpoint models.
Breast cancer was the most common type of cancer among females in the region, accounting for 18% of all cases in 2012, and was the fourth most common cause of cancer-related deaths (9%). Although incidence rates remain much higher in New Zealand and Australia, rapid rises in recent years were observed in several Asian countries. Large increases in breast cancer mortality rates also occurred in many areas, particularly Malaysia and Thailand, in contrast to stabilising trends in Hong Kong and Singapore, while decreases have been recorded in Australia and New Zealand. Mortality trends tended to be more favourable for women aged under 50 compared to those who were 50 years or older.
It is anticipated that incidence rates of breast cancer in developing countries throughout the Asia-Pacific region will continue to increase. Early detection and access to optimal treatment are the keys to reducing breast cancer-related mortality, but cultural and economic obstacles persist. Consequently, the challenge is to customise breast cancer control initiatives to the particular needs of each country to ensure the best possible outcomes.
概述亚太地区国家女性乳腺癌的发病率和死亡率。
从公开的癌症登记和死亡率数据库(如 GLOBOCAN)获取有关乳腺癌的统计信息,并补充来自个别癌症登记处的数据。比率直接按 Segi 世界标准人口进行年龄标准化,并使用连接点模型分析趋势。
乳腺癌是该地区女性中最常见的癌症类型,占 2012 年所有病例的 18%,也是癌症相关死亡的第四大常见原因(9%)。尽管新西兰和澳大利亚的发病率仍然高得多,但近年来几个亚洲国家的发病率迅速上升。许多地区的乳腺癌死亡率也大幅上升,尤其是马来西亚和泰国,而香港和新加坡的趋势则趋于稳定,而澳大利亚和新西兰的死亡率则有所下降。与 50 岁及以上的女性相比,50 岁以下的女性死亡率趋势更为有利。
预计亚太地区发展中国家的乳腺癌发病率将继续上升。早期发现和获得最佳治疗是降低乳腺癌相关死亡率的关键,但文化和经济障碍仍然存在。因此,挑战在于根据每个国家的特定需求定制乳腺癌控制计划,以确保获得最佳结果。